spacer
The Healthcare Sales & Marketing Network celebrates 20 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare Industry NewsFeed

 HSMN NewsFeed - 15 Oct 2018
CIVCO Radiotherapy Announces FDA 510k Clearance and CE Mark of their Solstice SRS Immobilization System
Devices Oncology FDA Regulatory
 HSMN NewsFeed - 15 Oct 2018
Abbott Names Robert B. Ford President, Chief Operating Officer
Diagnostics Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2018
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Oct 2018
Palette Life Sciences and Nestlé Skin Health Enter into Global Licensing Agreement for Deflux(R), Solesta(R) and Barrigel(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Oct 2018
Field Orthopaedics Forms Exclusive Partnership With Ortho Consulting Group to Launch New Micro Screw Into EMEA
Devices Orthopaedic Distribution Product Launch
 HSMN NewsFeed - 15 Oct 2018
Medivir to Focus on its Clinical Development and Appoints Uli Hacksell as Acting CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2018
FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing
Diagnostics FDA
 HSMN NewsFeed - 12 Oct 2018
Varian Expands Cancer Care Portfolio with Noona Healthcare Acquisition
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Oct 2018
Rockwell Medical Provides Update on IV Triferic
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Oct 2018
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Oct 2018
Lilly and Metastatic Breast Cancer Advocates Launch Thriver Movement to Elevate Understanding of the Daily Impact of the Disease, Encourage Public to do More for MBC
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 11 Oct 2018
Transseptal Solutions Announces FDA Clearance of Its Novel Transseptal Access System for Transseptal Puncture and Left Atrial Navigation
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 11 Oct 2018
FDA Approves Stiolto(R) Respimat(R) Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 Oct 2018
Paragon Genomics Introduces CleanPlex(R) UMI Panel for Ultrafast, Precise Analysis of Lung Cancer Hotspot Mutations at ASHG 2018
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 11 Oct 2018
Rigel Receives EMA Validation of the Marketing Authorization Application for Fostamatinib Disodium Hexahydrate in Chronic Immune Thrombocytopenia (ITP) in Adult Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Oct 2018
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of Investigational New Drug Application to Evaluate Tedopi(R) in Combination with Nivolumab in Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Oct 2018
bioAffinity Licenses CyPath(R) Lung to Precision Pathology Services
Diagnostics Oncology Licensing
 HSMN NewsFeed - 10 Oct 2018
SpineEX(R) Announces FDA Clearance of Sagittae(R) Lateral Lumbar Interbody Fusion Devices
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 10 Oct 2018
Tris Pharma Announces Hiring of Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Oct 2018
Lixte Biotechnology Files an IND with the FDA to Conduct a Phase 1b/2 Trial of LB-100 in Patients with Myelodysplastic Syndrome at Moffitt Cancer Center
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Oct 2018
Mike McDonald Joins Synergy MedSales as Chief Financial Officer
Devices Dermatology Personnel Distribution
 HSMN NewsFeed - 9 Oct 2018
Agendia Announces Level 1 Inclusion of MammaPrint(R) Breast Cancer Test in Updated National Comprehensive Cancer Network(R) (NCCN) Guidelines
Diagnostics Oncology Personalized Medicine
More stories   Return to NewsFeed  
RepFinder 2 - Find Great Medical Independent Sales Reps without recruiter fees.
RepFinder 2 - available on the Apple App Store for iPhone and iPad.